Andrew Cleeland’s successful exits from Adrian and Twelve led to his winning this year’s Medtech Conference Innovator of the Year award. Hear how he manages successful teams and what being in Medtech means to him.
Andrew Cleeland is an executive with 27 years in medtech in both private and public sector roles. Andrew is currently Vice President/General Manager of Medtronic’s Transcatheter Mitral Valve Venture following its recent acquisition of Twelve Inc., where he was the president and CEO.
00:40 – What does Medtech mean to you?
01:10 – How often do you meet with patients?
01:45 – It’s not just the patient. It’s the patient’s family.
02:50 – We’ve been able to attract people that this really matters to.
03:45 – `Companies are just group’s of human beings.
04:20 – What is the update on Twelve since the Medtronic acquisition?